| Mirrabooka Investments Limited (MIR) ORDINARY FULLY PAID |
Financials |
$609 |
Information Meetings - Presentation
|
13 Mar 2025 9:05AM |
$3.190 |
$2.720 |
fallen by
14.73%
|
|
| Nimy Resources Limited (NIM) ORDINARY FULLY PAID |
Materials |
$27 |
March 2025 Exploration Update
|
13 Mar 2025 9:04AM |
$0.046 |
$0.075 |
risen by
63.04%
|
|
NIM - Price-sensitive ASX Announcement
Full Release
Key Points
- Nimy Resources is exploring a new greenstone belt in Western Australia.
- Gallium discovery at Block 3 East includes the highest-grade intervals recorded in Australia.
- Collaboration with M2i Global Inc. aims to supply gallium to the US Defense Industrial Base.
- Drilling results show significant gallium concentrations across multiple drill holes.
- Growing demand for gallium due to its usage in semiconductors and defense applications.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Djerriwarrh Investments Limited (DJW) ORDINARY FULLY PAID |
Financials |
$754 |
Information Meetings - Presentation
|
13 Mar 2025 9:04AM |
$2.980 |
$2.870 |
fallen by
3.69%
|
|
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$304 |
Information Meetings - Presentation
|
13 Mar 2025 9:03AM |
$1.080 |
$0.960 |
fallen by
11.11%
|
|
| Ionic Rare Earths Limited (IXR) ORDINARY FULLY PAID |
Materials |
$88 |
IONIC TECH LCA CONFIRMS 60% LOWER CO2 FOR REO SUPPLY CHAIN
|
13 Mar 2025 9:03AM |
$0.006 |
$0.390 |
risen by
6,400%
|
|
IXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Peer review confirms up to 61% lower CO2 emissions from Ionic Technologies' recycling process.
- Study shows 53% reduction in CO2 emissions for Didymium oxide and 61% for Dysprosium oxide.
- Ionic Technologies launches MagNetZeroTM initiative to promote sustainable magnet supply chains.
- The analysis is based on a Life Cycle Assessment (LCA) compliant with ISO standards.
- Ionic Technologies aims to supply high purity rare earths with minimal environmental footprint.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ricegrowers Limited (SGLLV) CLASS B LIMITED-VOTING ORDINARY FULLY PAID |
Consumer Staple |
$822 |
Presentation to Australasian AgFood Conference
|
13 Mar 2025 9:02AM |
$9.760 |
$12.020 |
risen by
23.16%
|
|
SGLLV - Price-sensitive ASX Announcement
Full Release
Key Points
- SunRice operates in a cyclical environment affected by water availability and climate variability.
- The company has a dual class share structure that aligns the interests of Australian growers and investors.
- Recent years have seen record paddy prices for growers and dividends for investors.
- The theme of the conference is 'Sustainable Returns Through Cycles,' reflecting SunRice's strategy.
- SunRice sources rice from various countries to ensure consistent supply and returns.
- The company achieved record growth of $1.88 billion in revenue in FY2024.
- SunRice is committed to reaching net-zero emissions across its value chain by FY50.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Top End Energy Limited (TEE) ORDINARY FULLY PAID |
Energy |
$11 |
First Well Site Selected
|
13 Mar 2025 9:02AM |
$0.086 |
$0.039 |
fallen by
54.65%
|
|
TEE - Price-sensitive ASX Announcement
Full Release
Key Points
- Well Location Selected: The first location has been chosen.
- Secured Surface Use Agreements: Discussions with landowners are currently underway.
- Well Engineering Underway: Engaging consultants for well design.
- First steps towards becoming drill-ready have been taken.
- Encouraging data released from Koloma's exploration wells.
- The project holds exclusive rights to explore for hydrogen and helium.
- Near-term objectives include increasing lease hold and advancing pre-drill preparations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$8,677 |
Information Meetings - Presentation
|
13 Mar 2025 9:01AM |
$7.190 |
$6.890 |
fallen by
4.17%
|
|
| CSL Limited (CSL) ORDINARY FULLY PAID |
Health Care |
$70,963 |
Update - Dividend/Distribution - CSL
|
13 Mar 2025 9:01AM |
$250.370 |
$146.270 |
fallen by
41.58%
|
|
| DomaCom Limited (DCL) ORDINARY FULLY PAID |
Financials |
- |
Becoming a substantial holder
|
13 Mar 2025 9:00AM |
$0.011 |
$0.011 |
fallen by
0%
|
|
| Pepper Money Limited (PPM) ORDINARY FULLY PAID |
Financials |
$996 |
Application for quotation of securities - PPM
|
13 Mar 2025 9:00AM |
$1.445 |
$2.240 |
risen by
55.02%
|
|
| QPM Energy Limited (QPM) ORDINARY FULLY PAID |
Materials |
$107 |
Half Year Results Presentation
|
13 Mar 2025 8:59AM |
$0.048 |
$0.027 |
fallen by
43.75%
|
|
| QPM Energy Limited (QPM) ORDINARY FULLY PAID |
Materials |
$107 |
Half Yearly Report and Accounts
|
13 Mar 2025 8:58AM |
$0.048 |
$0.027 |
fallen by
43.75%
|
|
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$1,564 |
Update - Notification of buy-back - NEU
|
13 Mar 2025 8:57AM |
$11.100 |
$12.350 |
risen by
11.26%
|
|
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$264 |
Application for quotation of securities - BGD
|
13 Mar 2025 8:55AM |
$0.300 |
$1.105 |
risen by
268.33%
|
|
| Anteris Technologies Ltd (AVR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$875 |
Corporate Governance Statement and Appendix 4G
|
13 Mar 2025 8:54AM |
$11.070 |
$9.000 |
fallen by
18.70%
|
|
| National Australia Bank Limited (NAB) ORDINARY FULLY PAID |
Financials |
$143,625 |
Update - Notification of buy-back - NAB
|
13 Mar 2025 8:53AM |
$33.380 |
$46.820 |
risen by
40.26%
|
|
| TrivarX Ltd (TRI) ORDINARY FULLY PAID |
Health Care |
$27 |
Trading Halt
|
13 Mar 2025 8:52AM |
$0.015 |
$0.023 |
risen by
53.33%
|
|
TRI - Price-sensitive ASX Announcement
Full Release
Key Points
- TrivarX Limited requested a trading halt.
- The halt is pending an announcement regarding a share placement.
- Trading will resume on 17 March 2025 unless the announcement is released earlier.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$8,677 |
Update - Notification of buy-back - AFI
|
13 Mar 2025 8:52AM |
$7.190 |
$6.890 |
fallen by
4.17%
|
|
| Anteris Technologies Ltd (AVR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$875 |
2024 Financial Results and Corporate Update
|
13 Mar 2025 8:50AM |
$11.070 |
$9.000 |
fallen by
18.70%
|
|
AVR - Price-sensitive ASX Announcement
Full Release
Key Points
- Net Sales for 2024 were $2.7 million
- Net Loss after Income Tax for 2024 was $76.0 million
- Closing cash balance at December 31, 2024 was $70.5 million
- Anteris completed its U.S. IPO, raising $79.6 million
- The company's DurAVR® THV is set for a pivotal trial submission to the FDA in 2025
- Positive patient data was generated to support the IDE submission for DurAVR® THV
- The first two cases of the DurAVR® THV's European Early Feasibility Study were performed in January 2025
- Key presentations were made at major medical conferences to enhance awareness of DurAVR® THV
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,941 |
Notification of cessation of securities - MFG
|
13 Mar 2025 8:49AM |
$7.740 |
$11.550 |
risen by
49.22%
|
|
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,941 |
Update - Notification of buy-back - MFG
|
13 Mar 2025 8:48AM |
$7.740 |
$11.550 |
risen by
49.22%
|
|
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$304 |
Update - Notification of buy-back - AMH
|
13 Mar 2025 8:48AM |
$1.080 |
$0.960 |
fallen by
11.11%
|
|
| Anteris Technologies Ltd (AVR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$875 |
Annual Report to shareholders
|
13 Mar 2025 8:47AM |
$11.070 |
$9.000 |
fallen by
18.70%
|
|
AVR - Price-sensitive ASX Announcement
Full Release
Key Points
- Anteris is dedicated to revolutionizing cardiac care.
- The DurAVR® THV is a unique product for treating aortic stenosis.
- It employs proprietary ADAPT® anti-calcification tissue technology.
- The company has conducted successful clinical trials in the United States, Canada, and Europe.
- DurAVR® THV has shown promising hemodynamic improvements and patient outcomes.
- The technology aims to enhance the longevity and performance of heart valves.
- Anteris has received conditional FDA approval for early feasibility studies.
- The company emphasizes physician-led research and development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Avecho Biotechnology Limited (AVE) ORDINARY FULLY PAID |
Health Care |
$44 |
Avecho to present at NWR Virtual Healthcare Conference
|
13 Mar 2025 8:43AM |
$0.006 |
$0.012 |
risen by
100%
|
|